Mason Carrico

Stock Analyst at Stephens & Co.

(1.75)
# 3,152
Out of 4,858 analysts
81
Total ratings
29.41%
Success rate
-9.1%
Average return

Stocks Rated by Mason Carrico

Vericel
May 22, 2025
Reiterates: Overweight
Price Target: $67
Current: $45.70
Upside: +46.61%
Illumina
May 20, 2025
Reiterates: Overweight
Price Target: $105
Current: $87.98
Upside: +19.35%
Pacific Biosciences of California
May 15, 2025
Reiterates: Overweight
Price Target: $1.8
Current: $1.16
Upside: +55.17%
10x Genomics
May 15, 2025
Reiterates: Overweight
Price Target: $14
Current: $10.65
Upside: +31.46%
Hologic
May 13, 2025
Maintains: Overweight
Price Target: $77$70
Current: $65.14
Upside: +7.46%
CareDx
May 5, 2025
Reiterates: Overweight
Price Target: $40
Current: $19.85
Upside: +101.51%
Glaukos
May 2, 2025
Maintains: Overweight
Price Target: $140$115
Current: $95.64
Upside: +20.24%
Veracyte
Mar 26, 2025
Reiterates: Overweight
Price Target: $45
Current: $27.88
Upside: +61.41%
OncoCyte
Mar 26, 2025
Reiterates: Equal-Weight
Price Target: $4
Current: $2.80
Upside: +42.86%
Guardant Health
Mar 26, 2025
Reiterates: Overweight
Price Target: $55
Current: $50.09
Upside: +9.80%
Downgrades: Equal-Weight
Price Target: $3.5$1.8
Current: $1.33
Upside: +35.34%
Reiterates: Overweight
Price Target: $6
Current: $3.47
Upside: +72.91%
Reiterates: Equal-Weight
Price Target: $17
Current: $18.17
Upside: -6.44%
Reiterates: Overweight
Price Target: $52
Current: $38.87
Upside: +33.78%
Reiterates: Equal-Weight
Price Target: $20
Current: $5.24
Upside: +281.68%
Reiterates: Overweight
Price Target: $41
Current: $18.04
Upside: +127.27%
Reiterates: Overweight
Price Target: $125
Current: $165.22
Upside: -24.34%
Reiterates: Overweight
Price Target: $19
Current: $7.84
Upside: +142.35%